This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — A key House panel on Wednesday advanced several health care bills on Wednesday, including its first step toward a controversial effort to equalize Medicare payments between hospitals and physicianoffices.
A popular biologic medicine used to combat autoimmune diseases cost Medicare and its beneficiaries considerably more when the injectable treatment was obtained at pharmacies rather than injected in physicianoffices due to different methods for determining payment, a new analysis found.
Meanwhile, employment and salaries in non-retail settings—hospitals, physicianoffices, outpatient centers, and home healthcare—continued to grow. Find out during The 340B DrugPricing Program: Trends, Controversies, and Outlook , a new live video webinar with Adam J. These settings now employ one in three U.S.
What’s more, average base salaries for retail pharmacists have dropped, while salaries have risen for pharmacists employed by hospitals, physicianoffices, and other non-retail settings. . The 340B Drugpricing Program is a crucial topic for pharmacists.
When Medicare this week announced the first 10 medicines that will be included in its brand-new drugprice negotiation program, a J&J drug called Stelara that is used to treat Crohn’s disease was on the list. … Ninety-eight days may end up costing Johnson & Johnson , according to STAT.
… The Biden administration will fine drugmakers that hiked prices faster than the inflation rate on 27 medicines administered in physicianoffices , STAT notes. Pfizer had the most drugs on the list of any manufacturer, with five. AbbVie’s blockbuster rheumatoid arthritis drug, Humira, is on the list.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content